TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hightide Therapeutics Inc ( (HK:2511) ) has provided an announcement.
HighTide Therapeutics, Inc. has announced that its board of directors will convene on August 25, 2025, to review and approve the interim financial results for the first half of the year ending June 30, 2025. This meeting is significant as it will address the company’s financial performance and potentially influence its market positioning and stakeholder confidence.
More about Hightide Therapeutics Inc
HighTide Therapeutics, Inc. operates in the pharmaceutical industry, focusing on the development of innovative therapies for metabolic and digestive diseases. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 2,813,099
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$1.81B
For detailed information about 2511 stock, go to TipRanks’ Stock Analysis page.